The Enterprise Value as of December 2025 (TTM) for Teva Pharmaceutical Industries Limited (TEVA) is 47.90B

According to Teva Pharmaceutical Industries Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 47.90B. This represents a change of 33.84% compared to the average of 35.79B of the last 4 quarters.

Teva Pharmaceutical Industries Limited (TEVA) Historical Enterprise Value (quarterly & annually)

How has TEVA Enterprise Value performed in the past?

The mean historical Enterprise Value of Teva Pharmaceutical Industries Limited over the last ten years is 42.14B. The current 47.90B Enterprise Value has changed 11.26% with respect to the historical average. Over the past ten years (40 quarters), TEVA's Enterprise Value was at its highest in in the September 2016 quarter at 82.15B. The Enterprise Value was at its lowest in in the June 2023 quarter at 26.77B.

Teva Pharmaceutical Industries Limited (TEVA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Teva Pharmaceutical Industries Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Teva Pharmaceutical Industries Limited (TEVA) Average Enterprise Value

How has TEVA Enterprise Value performed in the past?

The current Enterprise Value of Teva Pharmaceutical Industries Limited (TEVA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Teva Pharmaceutical Industries Limited (TEVA) Enterprise Value vs. Peers

How is TEVA’s Enterprise Value compared to its peers?

Teva Pharmaceutical Industries Limited’s Enterprise Value is greater than Biogen Inc. (29.42B), greater than STERIS plc (25.48B), greater than DexCom, Inc. (26.21B), greater than BioNTech SE (10.05B), greater than Natera, Inc. (32.55B), greater than Insulet Corporation (21.55B), greater than Labcorp Holdings Inc. (27.61B), greater than Waters Corporation (24.62B), greater than Koninklijke Philips N.V. (28.49B), greater than Neurocrine Biosciences, Inc. (15.42B),

Build a custom stock screener for Teva Pharmaceutical Industries Limited (TEVA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Teva Pharmaceutical Industries Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Teva Pharmaceutical Industries Limited (TEVA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Teva Pharmaceutical Industries Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.